Mon, Dec 22, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Émergence selects Bluehive Capital for its 5th and last investment

Tuesday, May 27, 2014
Opalesque Industry Update, for New Managers - Emergence and NewAlpha Asset Management announce the fifth and final incubation partnership between the French managers-only seeding fund ‘Emergence Performance Absolue’ and BlueHive Capital.

Like its previous two investments, Emergence invested at the inception of the BlueHive Opportunities – Global Alpha, giving it an institutional visibility and sufficient size to meet the needs of French and international institutional investors.

Authorized under the new AIFM Directive, this new fund invests in various Event Driven strategies, including 'Special Situations' and 'M&A situations’.

The investment process, which has been successfully implemented since 2005 at Natixis CIB by BlueHive’s founding partners, researches continuously investment opportunities in listed companies. Combined with an innovative portfolio structuring and a rigorous risk control, the fundamental analysis of specific company catalysts such as M&A, Asset Sale, Spin-off or Management Changes, has generated in the past stable returns in various market environments.

BlueHive’s unique approach is based on the ability of the investment team to optimize their views by encompassing and trading every financial instrument of the capital structure (equity, volatility and credit).

Approved by the AMF in early 2014, BlueHive Capital was created by Sébastien Boucher, Alexandre de Sagazan and Cyril Slama. Since, they have been joined by four other experienced professionals who were part of the team led by Sébastien Boucher within the Equity Derivatives team at Natixis CIB from 2005 to 2012.

On top of the expected return of the five seeded funds, the leading French investors present in the seed vehicle, benefit from the growth of these innovative start-up managers and contribute to the recognition of their unique expertise in France and abroad.

With the sub-fund ‘Performance Absolue’ now fully invested, Emergence and NewAlpha are focusing on launching a second seed fund, specializing in European and French equities.

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  5. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for